Protalix BioTherapeutics PLX
NYSE PLX
$3.13 +0.28 (+9.62%)
As of: Nov 11, 2026 · 3:59 PM EST

Protalix BioTherapeutics (PLX) Depreciation & Amortization (CF) (2009 - 2026)

Updated

Protalix BioTherapeutics' Depreciation & Amortization (CF) was $132,000 in Q2 2026, up 12.8% from $117,000 a year earlier but down 67.3% from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Protalix BioTherapeutics' Depreciation & Amortization (CF) was $1.3 million through Jun 30, 2026, up 15.0% year-over-year; for FY2025, it came in at $1.47 million, up 12.3% from FY2024.

  • Depreciation & Amortization (CF) has now increased for three consecutive years, with a five-year compound annual growth rate of 2.4% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $1.3 million in FY2024 (+9.5%), $1.19 million in FY2023 (+8.3%), $1.1 million in FY2022 (-1.6%) and $1.12 million in FY2021 (-14.1%).
  • Quarterly Depreciation & Amortization (CF) has moved between $117,000 (Q2 2025) and $404,000 (Q1 2026) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for four straight quarters, with growth averaging 2.2% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q1 2026 (growth of 16.8%); the worst was Q2 2025 (a decline of 63.3%).
  • Per Business Quant data, PLX's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $404,000 (Q1 2026), $387,000 (Q4 2025) and $372,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Protalix BioTherapeutics 230.43 Mn 59.88 Mn 14.05 Mn 421,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 421,000.00
Jun 30, 2026 132,000.00
Mar 31, 2026 404,000.00
Dec 31, 2025 387,000.00
Sep 30, 2025 372,000.00
Jun 30, 2025 117,000.00
Mar 31, 2025 346,000.00
Dec 31, 2024 334,000.00
Sep 30, 2024 329,000.00
Jun 30, 2024 319,000.00
Mar 31, 2024 322,000.00
Dec 31, 2023 313,000.00
Sep 30, 2023 305,000.00
Jun 30, 2023 293,000.00
Mar 31, 2023 280,000.00
Dec 31, 2022 289,000.00
Sep 30, 2022 273,000.00
Jun 30, 2022 268,000.00
Mar 31, 2022 270,000.00
Dec 31, 2021 259,000.00
API Access

Protalix BioTherapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=PLX&period=max&api_key=YOUR_API_KEY